Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Findings From a National Diabetes Survey: Highlighting Progress and Opportunities for Diabetes Prevention and Care.

Kirkman MS, Tuncer D, Brown CE.

Diabetes Spectr. 2019 Aug;32(3):277-283. doi: 10.2337/ds18-0086.

PMID:
31462885
2.

Is it just me, or was that sexist? The role of sexism type and perpetrator race in identifying sexism.

Kirkman MS, Oswald DL.

J Soc Psychol. 2019 Jul 3:1-12. doi: 10.1080/00224545.2019.1634505. [Epub ahead of print]

PMID:
31268822
3.

Thank You Very Much.

Kirkman MS.

Acad Med. 2018 Aug;93(8):1144-1145. doi: 10.1097/ACM.0000000000002258. No abstract available.

PMID:
30044287
4.

Implementation and Evaluation of Shared Medical Appointments for Type 2 Diabetes at a Free, Student-Run Clinic in Alamance County, North Carolina.

Kahkoska AR, Brazeau NF, Lynch KA, Kirkman MS, Largay J, Young LA, Buse JB.

J Med Educ Train. 2018;2(1). pii: 032.

5.

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes Mellitus.

Kirkman MS, Mahmud H, Korytkowski MT.

Endocrinol Metab Clin North Am. 2018 Mar;47(1):81-96. doi: 10.1016/j.ecl.2017.10.002. Review.

PMID:
29407058
6.

Identifying insulin treatment responders with a composite measure: beyond Hba1c < 7% in patients with type 2 diabetes.

Conget I, Kirkman MS, Cao D, Wong M, Reviriego J, Kendall DM.

Curr Med Res Opin. 2018 Feb;34(2):329-336. doi: 10.1080/03007995.2017.1396968. Epub 2017 Nov 24.

PMID:
29065720
7.

Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.

El-Khatib FH, Balliro C, Hillard MA, Magyar KL, Ekhlaspour L, Sinha M, Mondesir D, Esmaeili A, Hartigan C, Thompson MJ, Malkani S, Lock JP, Harlan DM, Clinton P, Frank E, Wilson DM, DeSalvo D, Norlander L, Ly T, Buckingham BA, Diner J, Dezube M, Young LA, Goley A, Kirkman MS, Buse JB, Zheng H, Selagamsetty RR, Damiano ER, Russell SJ.

Lancet. 2017 Jan 28;389(10067):369-380. doi: 10.1016/S0140-6736(16)32567-3. Epub 2016 Dec 20. Erratum in: Lancet. 2017 Jan 28;389(10067):368. Lancet. 2017 Feb 4;389(10068):e2.

8.

Retinopathy predicts progression of fasting plasma glucose: An Early Diabetes Intervention Program (EDIP) analysis.

Patel YR, Kirkman MS, Considine RV, Hannon TS, Mather KJ.

J Diabetes Complications. 2017 Mar;31(3):605-610. doi: 10.1016/j.jdiacomp.2016.11.005. Epub 2016 Nov 12.

9.

Changes in Weight and Glucose Can Protect Against Progression in Early Diabetes Independent of Improvements in β-Cell Function.

Patel YR, Kirkman MS, Considine RV, Hannon TS, Mather KJ.

J Clin Endocrinol Metab. 2016 Nov;101(11):4076-4084. Epub 2016 Aug 17.

10.

Dual oral agent therapy for type 2 diabetes: Why don't our patients stick with it?

Kirkman MS.

J Diabetes Complications. 2016 Nov - Dec;30(8):1417-1418. doi: 10.1016/j.jdiacomp.2016.08.014. Epub 2016 Sep 1. No abstract available.

PMID:
27640122
11.

A call for comparative effectiveness research to learn whether routine clinical care decisions can protect from dementia and cognitive decline.

Dacks PA, Armstrong JJ, Brannan SK, Carman AJ, Green AM, Kirkman MS, Krakoff LR, Kuller LH, Launer LJ, Lovestone S, Merikle E, Neumann PJ, Rockwood K, Shineman DW, Stefanacci RG, Velentgas P, Viswanathan A, Whitmer RA, Williamson JD, Fillit HM.

Alzheimers Res Ther. 2016 Aug 20;8:33. doi: 10.1186/s13195-016-0200-3. Review.

12.

Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions.

Welsh KJ, Kirkman MS, Sacks DB.

Diabetes Care. 2016 Aug;39(8):1299-306. doi: 10.2337/dc15-2727. No abstract available.

13.

Osteoarthritis progression: is diabetes a culprit?

Kirkman MS.

Osteoarthritis Cartilage. 2015 Jun;23(6):839-40. doi: 10.1016/j.joca.2015.03.030. Epub 2015 Mar 28. No abstract available.

14.

Determinants of adherence to diabetes medications: findings from a large pharmacy claims database.

Kirkman MS, Rowan-Martin MT, Levin R, Fonseca VA, Schmittdiel JA, Herman WH, Aubert RE.

Diabetes Care. 2015 Apr;38(4):604-9. doi: 10.2337/dc14-2098. Epub 2015 Jan 8.

15.

The surveillance error grid.

Klonoff DC, Lias C, Vigersky R, Clarke W, Parkes JL, Sacks DB, Kirkman MS, Kovatchev B; Error Grid Panel.

J Diabetes Sci Technol. 2014 Jul;8(4):658-72. doi: 10.1177/1932296814539589. Epub 2014 Jun 13.

16.

Trends in the evidence level for the American Diabetes Association's "Standards of Medical Care in Diabetes" from 2005 to 2014.

Grant RW, Kirkman MS.

Diabetes Care. 2015 Jan;38(1):6-8. doi: 10.2337/dc14-2142. No abstract available.

PMID:
25538309
17.

Diabetes and cardiovascular disease in older adults: current status and future directions.

Halter JB, Musi N, McFarland Horne F, Crandall JP, Goldberg A, Harkless L, Hazzard WR, Huang ES, Kirkman MS, Plutzky J, Schmader KE, Zieman S, High KP.

Diabetes. 2014 Aug;63(8):2578-89. doi: 10.2337/db14-0020.

18.

Type 1 diabetes through the life span: a position statement of the American Diabetes Association.

Chiang JL, Kirkman MS, Laffel LM, Peters AL; Type 1 Diabetes Sourcebook Authors.

Diabetes Care. 2014 Jul;37(7):2034-54. doi: 10.2337/dc14-1140. No abstract available.

19.

Profound defects in β-cell function in screen-detected type 2 diabetes are not improved with glucose-lowering treatment in the Early Diabetes Intervention Program (EDIP).

Hannon TS, Kirkman MS, Patel YR, Considine RV, Mather KJ.

Diabetes Metab Res Rev. 2014 Nov;30(8):767-76. doi: 10.1002/dmrr.2553.

20.

Chronic kidney disease in diabetes: progressing towards higher costs.

Kirkman MS.

J Diabetes Complications. 2014 Jan-Feb;28(1):6-7. doi: 10.1016/j.jdiacomp.2013.10.001. Epub 2013 Oct 9. No abstract available.

PMID:
24183898
21.

Effect of acarbose to delay progression of carotid intima-media thickness in early diabetes.

Patel YR, Kirkman MS, Considine RV, Hannon TS, Mather KJ.

Diabetes Metab Res Rev. 2013 Oct;29(7):582-91. doi: 10.1002/dmrr.2433.

22.

Why we should screen for type 2 diabetes in high-risk patients.

Kirkman MS.

Am J Prev Med. 2013 Apr;44(4 Suppl 4):S371-4. doi: 10.1016/j.amepre.2012.12.021. No abstract available.

PMID:
23498301
23.

"New twist" in Diabetes Care for HbA(1c) reporting: "it takes two to tango"!

Cefalu WT, Kirkman MS.

Diabetes Care. 2012 Dec;35(12):2415-6. doi: 10.2337/dc12-1931. No abstract available.

24.

Diabetes in older adults: a consensus report.

Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, Huang ES, Korytkowski MT, Munshi MN, Odegard PS, Pratley RE, Swift CS; Consensus Development Conference on Diabetes and Older Adults.

J Am Geriatr Soc. 2012 Dec;60(12):2342-56. doi: 10.1111/jgs.12035. Epub 2012 Oct 25. No abstract available.

25.

Diabetes in older adults.

Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, Huang ES, Korytkowski MT, Munshi MN, Odegard PS, Pratley RE, Swift CS.

Diabetes Care. 2012 Dec;35(12):2650-64. doi: 10.2337/dc12-1801. Epub 2012 Oct 25. No abstract available.

26.

The American Diabetes Association diabetes research perspective.

Fonseca VA, Kirkman MS, Darsow T, Ratner RE.

Diabetes Care. 2012 Jun;35(6):1380-7. doi: 10.2337/dc12-9001. No abstract available. Erratum in: Diabetes Care. 2012 Jul;35(7):1629.

27.

The American Diabetes Association diabetes research perspective.

Fonseca VA, Kirkman MS, Darsow T, Ratner RE.

Diabetes. 2012 Jun;61(6):1338-45. doi: 10.2337/db12-0435. Review. No abstract available.

28.

Another shot to protect people with diabetes: add hepatitis B vaccination to the checklist.

Kirkman MS, Schaffner W.

Diabetes Care. 2012 May;35(5):941-2. doi: 10.2337/dc12-0164. No abstract available.

29.

Executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, Lernmark A, Metzger BE, Nathan DM.

Clin Chem. 2011 Jun;57(6):793-8. doi: 10.1373/clinchem.2011.163634. Epub 2011 May 26.

30.

Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, Lernmark A, Metzger BE, Nathan DM.

Clin Chem. 2011 Jun;57(6):e1-e47. doi: 10.1373/clinchem.2010.161596. Epub 2011 May 26.

31.

Position statement executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, Lernmark A, Metzger BE, Nathan DM; National Academy of Clinical Biochemistry.

Diabetes Care. 2011 Jun;34(6):1419-23. doi: 10.2337/dc11-9997.

32.

Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, Lernmark A, Metzger BE, Nathan DM; National Academy of Clinical Biochemistry; Evidence-Based Laboratory Medicine Committee of the American Association for Clinical Chemistry.

Diabetes Care. 2011 Jun;34(6):e61-99. doi: 10.2337/dc11-9998.

33.

Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review.

Moran A, Becker D, Casella SJ, Gottlieb PA, Kirkman MS, Marshall BC, Slovis B; CFRD Consensus Conference Committee.

Diabetes Care. 2010 Dec;33(12):2677-83. doi: 10.2337/dc10-1279. Review. No abstract available.

34.

Hemoglobin A1c to diagnose diabetes: why the controversy over adding a new tool?

Kirkman MS, Kendall DM.

Clin Chem. 2011 Feb;57(2):255-7. doi: 10.1373/clinchem.2010.148213. Epub 2010 Sep 15. No abstract available.

35.

Linking diabetes and cancer: a consensus on complexity.

Renehan A, Smith U, Kirkman MS.

Lancet. 2010 Jun 26;375(9733):2201-2. doi: 10.1016/S0140-6736(10)60706-4. No abstract available.

PMID:
20609959
36.

Aspirin for primary prevention of cardiovascular events in people with diabetes.

Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS; American Diabetes Association; American Heart Association; American College of Cardiology Foundation.

J Am Coll Cardiol. 2010 Jun 22;55(25):2878-86. doi: 10.1016/j.jacc.2010.04.003. Review. No abstract available.

37.

Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.

Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS; American Diabetes Association; American Heart Association; American College of Cardiology Foundation.

Diabetes Care. 2010 Jun;33(6):1395-402. doi: 10.2337/dc10-0555. No abstract available. Erratum in: Diabetes Care. 2010 Sep;33(9):2129-31. Diabetes Care. 2011 Jan;34(1):247-8.

38.

Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.

Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS.

Circulation. 2010 Jun 22;121(24):2694-701. doi: 10.1161/CIR.0b013e3181e3b133. Epub 2010 May 27. No abstract available.

PMID:
20508178
39.

Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis.

Kahn R, Alperin P, Eddy D, Borch-Johnsen K, Buse J, Feigelman J, Gregg E, Holman RR, Kirkman MS, Stern M, Tuomilehto J, Wareham NJ.

Lancet. 2010 Apr 17;375(9723):1365-74. doi: 10.1016/S0140-6736(09)62162-0. Epub 2010 Mar 29. Erratum in: Lancet. 2010 Apr 17;375(9723):1346.

PMID:
20356621
40.

How do we define cure of diabetes?

Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, McLaughlin S, Phillips GL 2nd, Robertson RP, Rubino F, Kahn R, Kirkman MS.

Diabetes Care. 2009 Nov;32(11):2133-5. doi: 10.2337/dc09-9036. No abstract available.

41.

American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE; American Association of Clinical Endocrinologists; American Diabetes Association.

Endocr Pract. 2009 May-Jun;15(4):353-69. doi: 10.4158/EP09102.RA. No abstract available.

PMID:
19454396
42.

American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE; American Association of Clinical Endocrinologists; American Diabetes Association.

Diabetes Care. 2009 Jun;32(6):1119-31. doi: 10.2337/dc09-9029. Epub 2009 May 8. No abstract available.

43.

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.

Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association.

J Am Coll Cardiol. 2009 Jan 20;53(3):298-304. doi: 10.1016/j.jacc.2008.10.008. Review. No abstract available.

44.

Comprehensive foot examination and risk assessment. A report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists.

Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, Lavery LA, LeMaster JW, Mills JL Sr, Mueller MJ, Sheehan P, Wukich DK.

Phys Ther. 2008 Nov;88(11):1436-43. No abstract available.

PMID:
19137633
45.

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.

Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association.

Circulation. 2009 Jan 20;119(2):351-7. doi: 10.1161/CIRCULATIONAHA.108.191305. Epub 2008 Dec 17. No abstract available. Erratum in: Circulation. 2009 Jun 30;119(25):e605.

PMID:
19095622
46.

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.

Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association.

Diabetes Care. 2009 Jan;32(1):187-92. doi: 10.2337/dc08-9026. Epub 2008 Dec 17. No abstract available. Erratum in: Diabetes Care. 2009 Apr;32(4):754.

47.

Comprehensive foot examination and risk assessment.

Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, Lavery LA, LeMaster JW, Mills JL Sr, Mueller MJ, Sheehan P, Wukich DK; Task Force of the Foot Care Interest Group of the American Diabetes Association.

Endocr Pract. 2008 Jul-Aug;14(5):576-83. No abstract available.

PMID:
18753100
48.

Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists.

Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, Lavery LA, Lemaster JW, Mills JL Sr, Mueller MJ, Sheehan P, Wukich DK; American Diabetes Association; American Association of Clinical Endocrinologists.

Diabetes Care. 2008 Aug;31(8):1679-85. doi: 10.2337/dc08-9021. No abstract available.

49.

Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care.

Kitzmiller JL, Block JM, Brown FM, Catalano PM, Conway DL, Coustan DR, Gunderson EP, Herman WH, Hoffman LD, Inturrisi M, Jovanovic LB, Kjos SI, Knopp RH, Montoro MN, Ogata ES, Paramsothy P, Reader DM, Rosenn BM, Thomas AM, Kirkman MS.

Diabetes Care. 2008 May;31(5):1060-79. doi: 10.2337/dc08-9020. No abstract available.

50.

Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program.

Kirkman MS, Shankar RR, Shankar S, Shen C, Brizendine E, Baron A, McGill J.

Diabetes Care. 2006 Sep;29(9):2095-101.

PMID:
16936159

Supplemental Content

Loading ...
Support Center